Cardinal taps Fiacco to succeed Burnside as top exec for Medicine Shoppe, Medicap
ST. LOUIS — Cardinal Health confirmed late Tuesday that it has named John Fiacco VP of its Medicine Shoppe and Medicap Pharmacy franchise division, effective Jan. 1.
Fiacco, a 23-year veteran of CVS/pharmacy, has held various leadership positions within Cardinal and Medicine Shoppe over the past decade, including VP field services for Medicine Shoppe. He will succeed Terry Burnside, who recently retired from his position as general manager of both franchise brands.
“He will take on the overall leadership of Medicine Shoppe and Medicap Pharmacy sales and operations,” Cardinal spokesperson Tara Schumacher told Drug Store News.
Fiacco will report to Steve Lawrence, SVP independent sales. Lawrence, said Schumacher, “is responsible for the overall leadership of Cardinal Health teams that serve all independent retail pharmacies, including Medicine Shoppe and Medicap Pharmacies.”
Cardinal now franchises 667 independent drug stores in the United States under the Medicine Shoppe and Medicap logos, according to Schumacher.
American Dietetic Association journal article emphasizes diabetes nutrition therapy
ST. LOUIS — The Journal of the American Dietetic Association has published a list of nutritional practice guidelines for people with Type 1 and Type 2 diabetes in its December issue.
Researchers reviewed research literature to create recommendations and practice guidelines centered on carbohydrates, protein intake, cardiovascular disease and weight management. Dietitians, according to the article, can encourage lifestyle changes and select appropriate interventions based on recommendations that include balancing nutritional intake with insulin doses, physical activity, weight management strategies and use of blood-glucose data.
“This publication has reviewed the process for developing the guidelines; identified major and contributing factors for diabetes nutrition therapy; reviewed and summarized research; and stated the nutrition practice recommendations that are to be integrated into the nutrition care process,” lead author and nutrition consultant Marion Franz said. “The nutrition practice guidelines provide recommendations for assessing client [and] patient needs and for selecting interventions, monitoring and evaluating outcomes.”
Antiviral drugs could cause insulin resistance, study finds
ST. LOUIS — Since the beginning of the HIV/AIDS epidemic in the early 1980s, one of the greatest advances has been antiviral drugs that have helped extend the lives of patients with viral infections.
But the drugs also cause insulin resistance, which can put people taking them at risk for diabetes and cardiovascular disease. According to a new study conducted by researchers at Washington University in St. Louis and published in the Journal of Biological Chemistry, compounds in the drugs known as protease inhibitors interfere with the body’s ability to control blood-sugar levels.
“Our lab has established that one of the effects of these drugs is blocking glucose transport, one of the most important steps in how insulin works,” WUSTL medical professor and lead study author Paul Hruz said. “Now that we’ve identified the main mechanism, we will look to develop new drugs that treat HIV but don’t cause diabetes.”